LATS Inhibitor Protects 6-OHDA Induced Neuronal Cell Death In Vitro and In Vivo-Reference-Cited by-同舟云学术

LATS Inhibitor Protects 6-OHDA Induced Neuronal Cell Death In Vitro and In Vivo

Published:2023 Issue:4 Volume:6 Page:144-149
ISSN:2434-432X
Container-title:BPB Reports
language:en
Short-container-title:

Author:

Fujimori Honoka¹,Ohba Takuya¹,Nakamura Shinsuke¹,Shimazawa Yoshinobu²,Takahashi Daiki²,Iwawaki Takumi²,Kamon Junji²,Shimazawa Masamitsu¹,Hara Hideaki³

Affiliation:

1. Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University

2. Biological Research Laboratories, Nissan Chemical Corporation

3. Laboratory of Collaborative Research for Innovative Drug Discovery, Gifu Pharmaceutical University

Publisher

Pharmaceutical Society of Japan

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/bpbreports/6/4/6_144/_pdf

Reference26 articles.

1. 1) Pan D. The hippo signaling pathway in development and cancer. Dev. Cell, 19, 491–505 (2010).

2. 2) Santucci M, Vignudelli T, Ferrari S, Mor M, Scalvini L, Bolognesi ML, et al. The hippo pathway and YAP/TAZ-TEAD protein-protein interaction as targets for regenerative medicine and cancer treatment. J. Med. Chem., 58, 4857–4873 (2015).

3. 3) LaQuaglia MJ, Grijalva JL, Mueller KA, Perez-Atayde AR, Kim HB, Sadri-Vakili G, et al. YAP subcellular localization and hippo pathway transcriptome analysis in pediatric hepatocellular carcinoma. Sci. Rep., 6, 30238 (2016).

4. 4) Gibson SB, Abbott D, Farnham JM, Thai KK, McLean H, Figueroa KP, et al. Population-based risks for cancer in patients with ALS. Neurology, 87, 289–294 (2016).

5. 5) Katisko K, Haapasalo A, Koivisto A, Krüger J, Hartikainen P, Korhonen V, et al. Low prevalence of cancer in patients with frontotemporal lobar degeneration. J. Alzheimers Dis., 62, 789–794 (2018).